[CAS NO. 1637735-84-2] FIIN-3
PRODUCTS SPECIFICATIONS [1637735-84-2]
DESCRIPTION [1637735-84-2]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 691.61 |
| Molecular Formula | C34H36Cl2N8O4 |
| SMILES | C=CC(NC1=CC=C(CN(C(NC2=C(Cl)C(OC)=CC(OC)=C2Cl)=O)C3=NC=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=C3)C=C1)=O |
Summary
IC50 & Target
|
FGFR1 13.1 nM (IC 50 ) |
FGFR2 21 nM (IC 50 ) |
FGFR3 31.4 nM (IC 50 ) |
FGFR4 35.3 nM (IC 50 ) |
In Vitro
FIIN-3 potently inhibits both WT FGFRs (EC 50 in the 1- to 41-nM range) and the gatekeeper mutant of FGFR2 (EC 50 of 64 nM). FIIN-3 also strongly inhibits EGFR, with an EC 50 of 43 nM. FIIN-3 shows good potency against gatekeeper mutant V564F; FIIN-3 also is potent against the gatekeeper-plus-1 mutant E565K; FIIN-3 also displays antiproliferative activity (with an EC 50 of 135 nM) against Ba/F3 cells transformed by the EGFR vIII fusion protein, which has a WT EGFR kinase domain. FIIN-3 shows even better activity against EGFR mutant L858R (EC 50 of 17 nM) and moderate activity, displaying an EC 50 of 231 nM, against the EGFR mutant L858R/T790M mutant. In WT FGFR2 Ba/F3 cells, FIIN-3 completely inhibits the FGFR2 autophosphorylation on Tyr656/657 at concentrations as low as 3 nM. In FGFR2 V564M Ba/F3 cells, FIIN-3 is capable of inhibiting the FGFR2 mutant V564M autophosphorylation with partial inhibition at 100 nM and complete inhibition observed at 300 nM [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 10 mg/mL ( 14.46 mM ; Need ultrasonic and warming)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 1.4459 mL | 7.2295 mL | 14.4590 mL |
| 5 mM | 0.2892 mL | 1.4459 mL | 2.8918 mL |
| 10 mM | 0.1446 mL | 0.7230 mL | 1.4459 mL |